Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.50 |
| ▸ | NMT1 | P30419 | 4/20 | 0.47 |
| ▸ | NMT2 | O60551 | 3/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 6/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | CTSD | P07339 | 2/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29777786 | 0.95 | FOLH1 (0.54) | FOLH1NMT1NMT2DPP4DPP8 | |
| SCHEMBL29777842 | 0.95 | FOLH1 (0.54) | FOLH1NMT1NMT2DPP4DPP8 | |
| SCHEMBL29803184 | 0.95 | FOLH1 (0.54) | FOLH1NMT1NMT2DPP4DPP8 | |
| SCHEMBL29803601 | 0.95 | FOLH1 (0.53) | FOLH1NMT1NMT2DPP4DPP8 | |
| SCHEMBL8366769 | 0.93 | FOLH1 (0.59) | FOLH1DPP4DPP8DPP9BACE1 | |
| SCHEMBL31344080 | 0.93 | FOLH1 (0.59) | FOLH1DPP4DPP8DPP9BACE1 | |
| SCHEMBL31682383 | 0.93 | FOLH1 (0.59) | FOLH1DPP4DPP8DPP9BACE1 | |
| SCHEMBL8366770 | 0.93 | FOLH1 (0.59) | FOLH1DPP4DPP8DPP9BACE1 | |
| SCHEMBL31676626 | 0.93 | FOLH1 (0.59) | FOLH1DPP4DPP8DPP9BACE1 | |
| SCHEMBL29777817 | 0.93 | FOLH1 (0.59) | FOLH1DPP4DPP8DPP9BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4013769-A2 | ZINC ACTIVATED THYMULIN AND METHODS OF PREPARATION AND ADMINISTRATION | Cytolyf Therapeutics LLC (US) | 2022-06-22 | — | — | EP | claimed |
| EP-4013769-A2 | ZINC ACTIVATED THYMULIN AND METHODS OF PREPARATION AND ADMINISTRATION | Cytolyf Therapeutics LLC (US) | 2022-06-22 | — | — | EP | disclosed |